These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 13372524)

  • 1. An evaluation of an adjuvant influenza virus vaccine tested against influenza B in 1954-1955.
    CRYNS WF; DAVENPORT FM; HENNESSY AV; HOUSER HB
    Am J Hyg; 1956 Nov; 64(3):304-13. PubMed ID: 13372524
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant influenza adenovirus vaccine.
    MEIKLEJOHN G
    JAMA; 1962 Feb; 179():594-7. PubMed ID: 14472203
    [No Abstract]   [Full Text] [Related]  

  • 3. Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule.
    HENNESSY AV; DAVENPORT FM
    Public Health Rep (1896); 1961 May; 76(5):411-9. PubMed ID: 13713365
    [No Abstract]   [Full Text] [Related]  

  • 4. SEROLOGICAL STUDIES ON ADULT VOLUNTEERS INOCULATED WITH OIL-ADJUVANT ASIAN INFLUENZA VACCINE. REPORT TO THE M.R.C. COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES.
    HOBSON D; LANE CA; BEARE AS; CHIVERS CP
    Br Med J; 1964 Aug; 2(5404):271-4. PubMed ID: 14160207
    [No Abstract]   [Full Text] [Related]  

  • 5. FIELD TRIALS OF ADJUVANT AND SALINE INFLUENZA VACCINES.
    HERBERT WJ; SELWYN S; PHILP JR
    Br J Prev Soc Med; 1965 Apr; 19(2):97-100. PubMed ID: 14319217
    [No Abstract]   [Full Text] [Related]  

  • 6. CLINICAL TRIALS OF OIL-ADJUVANT INFLUENZA VACCINES, 1960-3. REPORT TO THE MEDICAL RESEARCH COUNCIL BY ITS COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES.
    UJHAZY V
    Br Med J; 1964 Aug; 2(5404):267-71. PubMed ID: 14160206
    [No Abstract]   [Full Text] [Related]  

  • 7. A TRIAL OF OIL-ADJUVANT INFLUENZA VACCINE IN A NON-EPIDEMIC SEASON.
    HOWELL RW; STOTT AN
    Br J Ind Med; 1964 Oct; 21(4):259-64. PubMed ID: 14249893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A COMPARATIVE TRIAL OF OIL-ADJUVANT AND AQUEOUS POLYVALENT INFLUENZA VACCINES.
    HOWELL RW; MACKENZIE AB
    Br J Ind Med; 1964 Oct; 21(4):265-8. PubMed ID: 14249894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANTIBODY responses and clinical reactions with saline and oil adjuvant influenza virus vaccines.
    The Medical Research Council's Committee
    Br Med J; 1955 Nov; 2(4950):1229-32. PubMed ID: 13269837
    [No Abstract]   [Full Text] [Related]  

  • 10. [Application and prospect of natural active ingredients of traditional Chinese medicine in immunological adjuvant for influenza vaccine].
    Zhang Y; Li XL; Li HY; Wu XX; Dong YZ; Zhao J
    Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):5985-5992. PubMed ID: 38114204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influenza virus and other viruses. Antiinfluenza vaccine adjuvants. The hemagglutination phenomenon. Non-specific inhibition. II].
    LACORTE JG
    Rev Bras Med; 1960 Apr; 17():334-8. PubMed ID: 13758108
    [No Abstract]   [Full Text] [Related]  

  • 13. MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.
    O'Hagan DT
    Expert Rev Vaccines; 2007 Oct; 6(5):699-710. PubMed ID: 17931151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
    Baldo V; Menegon T; Buoro S; Scalici C; Vesco A; Perale S; Boato W; Carletti M; Bonello C; Dalla Costa D; Trivello R
    Ann Ig; 1999; 11(5):369-74. PubMed ID: 10596424
    [No Abstract]   [Full Text] [Related]  

  • 15. MF59™ as a vaccine adjuvant: a review of safety and immunogenicity.
    El Sahly H
    Expert Rev Vaccines; 2010 Oct; 9(10):1135-41. PubMed ID: 20923265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccine with squalene adjuvant: new preparation. No better than available products.
    Prescrire Int; 2004 Dec; 13(74):206-8. PubMed ID: 15599987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactions to influenza vaccine.
    SEAL JR
    U S Armed Forces Med J; 1955 Nov; 6(11):1559-63. PubMed ID: 13267948
    [No Abstract]   [Full Text] [Related]  

  • 18. Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.
    Baldwin SL; Hsu FC; Van Hoeven N; Gage E; Granger B; Guderian JA; Larsen SE; Lorenzo EC; Haynes L; Reed SG; Coler RN
    Front Immunol; 2018; 9():295. PubMed ID: 29515589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
    Ichinohe T; Watanabe I; Tao E; Ito S; Kawaguchi A; Tamura S; Takahashi H; Sawa H; Moriyama M; Chiba J; Komase K; Suzuki Y; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predetermination by infection and by vaccination of antibody response to influenza virus vaccines.
    DAVENPORT FM; HENNESSY AV
    J Exp Med; 1957 Dec; 106(6):835-50. PubMed ID: 13481247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.